Last 47 quarters of trend data · Healthcare · Medical - Distribution
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Prestige Consumer Healthcare Inc.'s quarterly P/E stands at 15.9x, down 0.6% year-over-year. EV/EBITDA has compressed 10.0% YoY to 11.1x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 12.72 | 15.90 | 18.14 | 21.01 | 21.49 | 16.00 | 16.54 | 17.56 | 18.51 | 14.44 | 13.36 | 14.02 | — |
| — | -0.6% | +9.7% | +19.6% | +16.1% | +10.8% | +23.8% | +25.3% | — | -4.0% | +9.4% | +3.9% | — | |
| P/S Ratio | 2.27 | 2.62 | 2.80 | 3.99 | 3.63 | 3.36 | 3.18 | 3.24 | 3.29 | 2.71 | 2.50 | 2.67 | 2.73 |
| — | -22.2% | -11.8% | +23.1% | +10.1% | +23.9% | +27.1% | +21.3% | +20.8% | -4.8% | +15.5% | -0.8% | +7.9% | |
| P/B Ratio | 1.49 | 1.62 | 1.68 | 2.14 | 2.35 | 2.18 | 2.08 | 2.06 | 2.21 | 1.92 | 1.86 | 2.02 | 2.16 |
| — | -25.7% | -19.1% | +4.1% | +6.4% | +13.9% | +11.6% | +2.2% | +2.3% | +2.9% | +20.6% | +7.1% | +26.0% | |
| P/FCF | 10.62 | 9.85 | 13.88 | 12.73 | 18.44 | 15.36 | 13.30 | 16.13 | 14.31 | 11.04 | 12.03 | 16.00 | 13.82 |
| — | -35.9% | +4.4% | -21.1% | +28.8% | +39.1% | +10.5% | +0.8% | +3.6% | -25.3% | +6.0% | +22.7% | +22.8% | |
| EV / EBITDA | 9.62 | 11.11 | 11.44 | 15.37 | 13.72 | 12.34 | 12.83 | 14.12 | 13.18 | 11.16 | 10.65 | 11.49 | — |
| — | -10.0% | -10.8% | +8.8% | +4.1% | +10.6% | +20.5% | +22.9% | — | -5.5% | +0.5% | -1.4% | — | |
| EV / EBIT | 10.48 | 13.80 | 12.62 | 16.96 | 15.50 | 13.32 | 13.74 | 15.83 | 14.36 | 12.24 | 11.60 | 12.33 | — |
| — | +3.6% | -8.2% | +7.1% | +7.9% | +8.8% | +18.5% | +28.3% | — | -6.4% | -1.2% | -4.4% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Prestige Consumer Healthcare Inc.'s operating margin was 29.1% in Q3 2026, up 0.0 pp QoQ and down 2.6 pp YoY.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.8% | 55.5% | 56.2% | 54.2% | 59.2% | 55.5% | 55.5% | 54.7% | 54.8% | 55.9% | 55.9% | 55.4% | 53.8% |
| — | +0.1% | +1.3% | -0.9% | +8.0% | -0.7% | -0.7% | -1.3% | +1.9% | +2.3% | +0.4% | -4.2% | -3.5% | |
| Operating Margin | 29.6% | 29.1% | 29.1% | 28.8% | 29.8% | 31.7% | 29.7% | 27.0% | 29.7% | 30.7% | 30.8% | 30.5% | -98.3% |
| — | -8.1% | -2.3% | +6.6% | +0.5% | +3.1% | -3.5% | -11.6% | +130.2% | -2.9% | +5.7% | -2.9% | -438.9% | |
| Net Margin | 18.9% | 16.5% | 15.4% | 19.0% | 16.9% | 21.0% | 19.2% | 18.4% | 17.9% | 18.8% | 18.7% | 19.1% | -84.1% |
| — | -21.6% | -19.7% | +3.6% | -5.4% | +12.1% | +2.5% | -3.7% | +121.2% | -0.5% | +6.1% | -4.4% | -531.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 12.3% | 2.6% | 2.3% | 2.6% | 2.8% | 3.5% | 3.2% | 2.9% | 3.0% | 3.4% | 3.6% | 3.6% | -15.4% |
| — | -26.3% | -28.0% | -12.6% | -8.9% | +2.5% | -10.3% | -19.2% | +119.8% | +7.6% | +11.5% | +4.1% | -556.2% | |
| ROA | 6.4% | 1.3% | 1.2% | 1.4% | 1.5% | 1.8% | 1.6% | 1.5% | 1.5% | 1.6% | 1.6% | 1.6% | -6.8% |
| — | -26.7% | -25.2% | -6.2% | +0.2% | +15.5% | +2.4% | -6.9% | +121.9% | +13.7% | +15.7% | +5.8% | -576.6% | |
| ROIC | 9.1% | 2.2% | 2.2% | 1.9% | 2.4% | 2.5% | 2.3% | 2.0% | 2.2% | 2.4% | 2.4% | 2.3% | -7.3% |
| — | -12.0% | -5.8% | -1.2% | +6.7% | +5.9% | -4.0% | -15.1% | +130.9% | +10.2% | +15.5% | +8.4% | -482.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Prestige Consumer Healthcare Inc.'s Debt/EBITDA ratio is 12.2x — elevated, raising questions about debt serviceability. The current ratio has weakened 15.6% YoY to 3.11x, tightening the short-term liquidity position. Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.57 | 0.60 | 0.57 | 0.56 | 0.57 | 0.57 | 0.61 | 0.66 | 0.69 | 0.76 | 0.83 | 0.90 | 0.94 |
| — | +4.5% | -6.9% | -14.4% | -17.4% | -24.2% | -26.5% | -27.3% | -27.1% | -11.7% | -7.8% | -4.7% | -1.1% | |
| Debt / EBITDA | 2.85 | 12.19 | 11.92 | 13.13 | 10.91 | 10.39 | 11.80 | 13.76 | 12.66 | 12.84 | 13.34 | 14.40 | — |
| — | +17.3% | +1.0% | -4.6% | -13.8% | -19.1% | -11.6% | -4.5% | — | -15.4% | -15.6% | -8.4% | — | |
| Current Ratio | 4.20 | 3.11 | 3.70 | 4.38 | 4.20 | 3.68 | 3.56 | 3.23 | 3.20 | 3.09 | 2.99 | 2.66 | 2.44 |
| — | -15.6% | +3.8% | +35.6% | +31.2% | +19.0% | +19.0% | +21.5% | +31.5% | +21.1% | +35.4% | +27.3% | +19.2% | |
| Quick Ratio | 2.82 | 1.93 | 2.51 | 2.99 | 2.82 | 2.20 | 2.10 | 1.90 | 2.02 | 1.92 | 1.75 | 1.51 | 1.43 |
| — | -12.1% | +19.7% | +57.2% | +39.6% | +14.4% | +20.0% | +26.0% | +41.3% | +23.1% | +35.8% | +22.7% | +18.5% | |
| Interest Coverage | 7.07 | 7.73 | 7.94 | 7.03 | 8.22 | 8.03 | 6.87 | 5.48 | 5.38 | 5.24 | 5.01 | 4.81 | -14.81 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying PBH stock.
Prestige Consumer Healthcare Inc.'s current P/E is 12.7x. The average P/E over the last 4 quarters is 19.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Prestige Consumer Healthcare Inc.'s current operating margin is 29.6%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Prestige Consumer Healthcare Inc.'s business trajectory between earnings reports.